Abstract
Aim
We hypothesized that certain effects of the general anaesthetic thiopental are dependent on NO-related mechanisms, which were consequently counteracted by stable gastric pentadecapeptide BPC 157.
Main methods
(1) All rats intraperitoneally received thiopental (20, 30, 40, and 50 mg/kg) while medication BPC 157 (10 μg/kg, 10 ng/kg, and 10 pg/kg) was given intraperitoneally at 5 min before thiopental. (2) To determine NO-related mechanisms, all rats received intraperitoneally thiopental 40 mg/kg while BPC 157 (10 μg/kg), l-NAME (10 mg/kg) and l-arginine (30 mg/kg) were applied alone and/or combined. BPC 157 was given at 25 min before thiopental while l-NAME, l-arginine, alone and/or combined, were applied at 20 min before thiopental.
Key findings
(1) BPC 157 own effect on thiopental anaesthesia: BPC 157 (10 ng/kg and 10 μg/kg) caused a significant antagonism of general anaesthesia produced by thiopental with a parallel shift of the dose–response curve to the right. (2) l-NAME-l-arginine-BPC 157 interrelations: l -NAME: Thiopental-induced anaesthesia duration was tripled. l-arginine: Usual thiopental anaesthesia time was not influenced. Active only when given with l-NAME or BPC 157: potentiating effects of l-NAME were lessened, not abolished; shortening effect of BPC 157: abolished. BPC 157 and l -NAME: Potentiating effects of l-NAME were abolished. BPC 157 and l -NAME and l-arginine: BPC 157 +l-NAME +l-arginine rats exhibited values close to those in BPC 157 rats.
Significance
Thiopental general anaesthesia is simultaneously manipulated in both ways with NO system activity modulation, l-NAME (prolongation) and BPC 157 (shortening/counteraction) and l-arginine (interference with l-NAME and BPC 157).
Similar content being viewed by others
References
Agoston S, Salt PJ, Erdmann W, Hilkemeijer T, Bencini A, Langrehr D (1980) Antagonism of ketamine–diazepam anesthesia by 4-aminopyridine in human volunteers. Br J Anesth 52:367–369
Aziz Q, Thompson DG (1998) Brain-gut axis in health and disease. Gastroenterology 114:559–578
Balenovic D, Bencic ML, Udovicic M et al (2009) Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system. Regul Pept 156:83–89
Balenovic D, Barisic I, Prkacin I et al (2012) Mortal furosemide-hypokalemia-disturbances in rats NO-system related. Shorten survival by l-NAME. Therapy benefit with BPC 157 more than with l-arginine. J Clin Exp Cardiolog 3:201
Barisic M, Balenovic D, Klicek R et al (2013) Mortal hyperkalemia disturbance in rats is NO-system related. The life saving effect of pentadecapeptide BPC 157. Regul Pept 181:50–66
Blagaic AB, Blagaic V, Romic Z, Sikiric P (2004) The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Eur J Pharmacol 499:285–290
BobanBlagaic A, Blagaic V, Mirt M et al (2005) Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats. Eur J Pharmacol 512:173–179
BobanBlagaic A, Turcic P, Blagaic V et al (2009) Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice. J Physiol Pharmacol 60(Suppl 7):177–181
Boban-Blagaic A, Blagaic V, Romic Z et al (2006) The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-l-arginine methyl ester and l-arginine. Med Sci Monit 12:36–45
Breese GR, Cooper BR, Prange AJ, Cott JM, Lipton MA (1974) Antagonism of ethanol narcosis by thyrotropin releasing hormone. Life Sci 14:1053–1063
Campagna JA, Miller KW, Forman SA (2003) Mechanisms of actions of inhaled anesthetics. N Engl J Med 348:2110–2124
Carta M, Murru L, Barabino E, Talani G, Sanna E, Biggio G (2008) Isoniazid-induced reduction in GABAergic neurotransmission alters the function of the cerebellar cortical circuit. Neuroscience 154:710–719
Cesarec V, Becejac T, Misic M et al (2012) Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy. Eur J Pharmacol 701:203–212
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH (2011) The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol 110:774–780
Chang CH, Tsai WC, Hsu YH, Pang JH (2014) Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 19:19066–19077
Dickinson R, de Sousa SL, Lieb WR, Franks NP (2002) Selective synaptic actions of thiopental and its enantiomers. Anesthesiology 96:884–892
Dolin SJ, Halsey MJ, Little HJ (1988) Effects of the calcium channel agonist, Bay K 8644, on general anesthetic potency in mice. Br J Pharmacol 94:413–422
Foster AC, Kemp JA (2006) Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol 6:7–17
French TA, Massarano JM, Weiner N (1993) Influence of thyrotropin releasing hormone and catecholaminergic interactions on CNS ethanol sensitivity. Alc Clin Exp Res 17:99–106
Galley HF, Webster NR (1996) Brain nitric oxide synthase activity is decreased by intravenous anesthetics. Anesth Analg 83:591–594
Gasulla J, Calvo DJ (2015) Enhancement of tonic and phasic GABAergic currents following nitric oxide synthase inhibition in hippocampal CA1 pyramidal neurons. Neurosci Lett 590:29–34
Gjurasin M, Miklic P, Zupancic P et al (2010) Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury. Regul Pept 160:33–41
Grabarevic Z, Tisljar M, Artukovic B et al (1997) The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J Physiol Paris 91:139–149
Gursoy S, Berkan O, Bagcivan I, Kaya T, Yildirim K, Mimaroglu C (2007) Effects of intravenous anesthetics on the human radial artery used as a coronary artery bypass graft. J Cardiothorac Vasc Anesth 21:41–44
Huang T, Zhang K, Sun L et al (2015) Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther 9:2485–2499
Ilic S, Brcic I, Mester M et al (2009) Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats. J Physiol Pharmacol 60(Suppl 7):107–114
Ilic S, Drmic D, Zarkovic K et al (2010) High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736). J Physiol Pharmacol 61:241–250
Ilic S, Drmic D, Franjic S et al (2011a) Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions. Life Sci 88(11–12):535–542
Ilic S, Drmic D, Zarkovic K et al (2011b) Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats. Eur J Pharmacol 667(1–3):322–329
Jelovac N, Sikiric P, Rucman R et al (1998) A novel pentadecapeptide, BPC 157, blocks the stereotypy produced acutely by amphetamine and the development of haloperidol-induced supersensitivity to amphetamine. Biol Psychiatry 43:511–519
Jelovac N, Sikiric P, Rucman R et al (1999a) Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. Eur J Pharmacol 379:19–31
Jelovac N, Sikiric P, Rucman R et al (1999b) The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam. Chin J Physiol 42:171–179
Johns RA, Moscicki JC, DiFazio CA et al (1992) Nitric oxide synthase inhibitor dose-dependently and reversibly reduces the threshold for halothane anesthesia. A role for nitric oxide in mediating consciousness? Anesthesiology 77:779–784
Klicek R, Sever M, Radic B et al (2008) Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system. J Pharmacol Sci 108:7–17
Klicek R, Kolenc D, Suran J et al (2013) Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability. J Physiol Pharmacol 64:597–612
Leeuwin RS, Vanderwal JK, Spanjer W (1984) Interactions of cholinesterase inhibitors and glucocorticoids with ketamine and pentobarbitone-induced general anesthesia in the rat: possible effects on central cholinergic activity. Br J Pharmacol 82:339–347
Little HJ, Clark A, Watson WP (2000) Investigations into pharmacological antagonism of general anesthesia. Br J Pharmacol 129:1755–1763
Lovric-Bencic M, Sikiric P, Hanzevacki JS et al (2004) Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse. J Pharmacol Sci 95:19–26
Matsushita M, Yonemori F, Hamada A, Toide K, Iwata K (1995) Effect of JTP-2942, a novel thyrotropin releasing hormone analog, on pentobarbital-induced anesthesia in rats. Eur J Pharmacol 276:177–182
Mohler H (1992) GABAergic synaptic transmission. Regulation by drugs. Arzneim Forsch Drug Res 42:211–214
Moreno L, Martínez-Cuesta MA, Muedra V, Beltrán B, Esplugues J (1997) Role of the endothelium in the relaxation induced by propofol and thiopental in isolated arteries from man. J Pharm Pharmacol 49:430–432
Prkacin I, Aralica G, Perovic D et al (2001a) Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats. J Physiol Paris 95:295–301
Prkacin I, Separovic J, Aralica G et al (2001b) Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine. J Physiol Paris 95:315–324
Roh WS, Ding X, Murray PA (2006) Propofol and thiopental attenuate adenosine triphosphate-sensitive potassium channel relaxation in pulmonary veins. Am J Physiol Lung Cell Mol Physiol 291:636–643
Russo H, Brès J, Duboin MP, Roquefeuil B (1995) Pharmacokinetics of thiopental after single and multiple intravenous doses in critical care patients. Eur J Clin Pharmacol 49:127–137
Seiwerth S, Brcic L, Vuletic LB et al (2014) BPC 157 and blood vessels. Curr Pharm Des 20:1121–1125
Sellin LC, Laakso PS (1987) Antagonism of ethanol-induced depressant effects by 4-aminopyridine in the central nervous system of the rat. Neuropharmacology 26:385–390
Sikiric P, Petek M, Rucman R et al (1993) A new gastric juice peptide, BPC.An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87:313–327
Sikiric P, Seiwerth S, Grabarevic Z et al (1997) The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-l-arginine methylester and l-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol 332:23–33
Sikiric P, Marovic A, Matoz W et al (1999) A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson’s disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine. J Physiol Paris 93:505–512
Sikiric P, Separovic J, Buljat G et al (2000) The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt’s test and chronic unpredictable stress in rats. A comparison with antidepressants. J Physiol Paris 94:99–104
Sikiric P, Jelovac N, Jelovac-Gjeldum A et al (2001) Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test. Acta Pharmacol Sin 22:225–230
Sikiric P, Jelovac N, Jelovac-Gjeldum A et al (2002) Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances. Acta Pharmacol Sin 23:412–422
Sikiric P, Seiwerth S, Brcic L et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response. Inflammopharmacology 14:214–221
Sikiric P, Seiwerth S, Brcic L et al (2010) Revised Robert’s cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr Pharm Des 16:1224–1234
Sikiric P, Seiwerth S, Rucman R, et al. (2011) Stable gastric pentadecapeptide BPC 157:novel therapy in gastrointestinal tract. Curr Pharm Des. 17:1612–1632
Sikiric P, Seiwerth S, Rucman R et al (2013) Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des 19:76–83
Sikiric P, Seiwerth S, Rucman R et al (2014) Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des 20:1126–1135
Skorjanec S, Kokot A, Drmic D et al (2015) Duodenocutaneous fistula in rats as a model for “wound healing-therapy” in ulcer healing: the effect of pentadecapeptide BPC 157, l-nitro-arginine methylester and l-arginine. J Physiol Pharmacol 66:581–590
Soares de Moura R, Rios AA, de Oliveira LF et al (2001) The effects of nitric oxide synthase inhibitors on the sedative effect of clonidine. Anesth Analg 93:1217–1221
Stupnisek M, Kokot A, Drmic D et al (2015) Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, l-NAME and l-arginine. PLoS One 10:e0123454
Tkalcevic VI, Cuzic S, Brajsa K et al (2007) Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol 570:212–221
Toda N, Toda H, Hatano Y (2007) Nitric oxide: involvement in the effects of anesthetic agents. Anesthesiology 107:822–842
Tohyama Y, Sikiric P, Diksic M (2004) Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain: alpha-methyl-l-tryptophan autoradiographic measurements. Life Sci 76:345–357
Tonner PH, Scholz J, Lamberz L, Schlamp N, Schulte AM, Esch J (1997) Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopuslaevis. Anesthesiology 87:1479–1485
Treit D (1990) A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics. Pharmacol Biochem Behav 36:203–205
Tudor M, Jandric I, Marovic A et al (2010) Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul Pept 160:26–32
Weber M, Motin L, Gaul S, Beker F, Fink RH, Adams DJ (2005) Intravenous anaesthetics inhibit nicotinic acetylcholine receptor-mediated currents and Ca2+ transients in rat intracardiac ganglion neurons. Br J Pharmacol 144:98–107
Acknowledgements
This research was supported from Ministry of Science, Education and Sports, Republic of Croatia (Grant No. 108-1083570-3635).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors report no conflict of interest.
Rights and permissions
About this article
Cite this article
Zemba, M., Cilic, A.Z., Balenovic, I. et al. BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by l-NAME/thiopental combination. Inflammopharmacol 23, 329–336 (2015). https://doi.org/10.1007/s10787-015-0249-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-015-0249-9